Benitec Biopharma Inc. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported revenue was USD 0.014 million compared to USD 0.025 million a year ago. Net loss was USD 5.41 million compared to USD 4.82 million a year ago. Basic loss per share from continuing operations was USD 3.4 compared to USD 10.03 a year ago. Diluted loss per share from continuing operations was USD 3.4 compared to USD 10.03 a year ago.
For the six months, revenue was USD 0.014 million compared to USD 0.025 million a year ago. Net loss was USD 10.5 million compared to USD 9.87 million a year ago. Basic loss per share from continuing operations was USD 9.35 compared to USD 20.57 a year ago. Diluted loss per share from continuing operations was USD 9.35 compared to USD 20.57 a year ago.